Cargando…

Therapeutic Properties of Highly Selective β-blockers With or Without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients With Cardiovascular Disease

Bisoprolol and nebivolol are highly selective β(1)-adrenoceptor antagonists, with clinical indications in many countries within the management of heart failure with reduced left ventricular ejection fraction (HFrEF), ischaemic heart disease (IHD), and hypertension. Nebivolol has additional vasodilat...

Descripción completa

Detalles Bibliográficos
Autores principales:	AlHabeeb, Waleed, Mrabeti, Sanaa, Abdelsalam, Ahmed Adel Ibrahim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9519665/ https://www.ncbi.nlm.nih.gov/pubmed/34106365 http://dx.doi.org/10.1007/s10557-021-07205-y

Ejemplares similares

Comparison of Nebivolol and Bisoprolol for Cardiovascular Mortality in Hypertensive Patients
por: Kumar, Ratan, et al.
Publicado: (2019)

Comparison of Effect of Nebivolol and Bisoprolol on Sexual Function of Hypertensive Female Patients
por: Kumar, Nomesh, et al.
Publicado: (2021)

Effects of the vasodilating beta-blocker nebivolol on smoking-induced endothelial dysfunction in young healthy volunteers
por: Schmidt, André C, et al.
Publicado: (2008)

Nebivolol: A Novel Beta-Blocker with Nitric Oxide-Induced Vasodilatation
por: Weiss, Robert
Publicado: (2006)

The β-blocker Nebivolol Is a GRK/β-arrestin Biased Agonist
por: Erickson, Catherine E., et al.
Publicado: (2013)

Protective Effects of the Third Generation Vasodilatory Βeta - Blocker Nebivolol against D-Galactosamine - Induced Hepatorenal Syndrome in Rats
por: Atwa, Ahmed, et al.
Publicado: (2017)

The β1 Adrenergic Blocker Nebivolol Ameliorates Development of Endotoxic Acute Lung Injury
por: Nurlu Temel, Esra, et al.
Publicado: (2023)

Protective Effects of Vasodilatory Βeta-Blockers Carvedilol and Nebivolol against Glycerol Model of Rhabdomyolysis-Induced Acute Renal Failure in Rats
por: Atwa, Ahmed, et al.
Publicado: (2016)

Heart failure disease management program: A review
por: AlHabeeb, Waleed
Publicado: (2022)

Hiding in Plain Sight: Nebivolol Exhibits Compelling Tocolytic Properties
por: Barnett, Scott D., et al.
Publicado: (2018)

Continuation of Angiotensin Converting Enzyme Inhibitors in Acute Heart Failure
por: AlHabeeb, Waleed, et al.
Publicado: (2021)

Chiral Separation of Beta-blockers by High-performance Liquid Chromatography and Determination of Bisoprolol Enantiomers in Surface Waters
por: Pocrnić, Marijana, et al.
Publicado: (2020)

Effect of beta-1-blocker, nebivolol, on central aortic pressure and arterial stiffness in patients with essential hypertension
por: Soanker, Radhika, et al.
Publicado: (2012)

Treatment with β-blocker nebivolol ameliorates oxidative stress and endothelial dysfunction in tenofovir-induced nephrotoxicity in rats
por: Nascimento, Mariana Moura, et al.
Publicado: (2022)

Nebivolol-induced gynecomastia
por: Köklü, Erkan, et al.
Publicado: (2015)

β-Blockade for Patients with Hypertension, Ischemic Heart Disease or Heart Failure: Where are We Now?
por: Pathak, Atul, et al.
Publicado: (2021)

THE VASODILATOR AND VASOCONSTRICTOR PROPERTIES OF BLOOD SERUM AND PLASMA
por: Stewart, Hugh A., et al.
Publicado: (1912)

Cost-effectiveness analysis of nebivolol and metoprolol in essential hypertension: A pharmacoeconomic comparison of antihypertensive efficacy of beta blockers
por: Patel, Rachna S., et al.
Publicado: (2014)

In Vitro Drug Repurposing: Focus on Vasodilators
por: Ribeiro, Eduarda, et al.
Publicado: (2023)

(S,S,S,S)-Nebivolol hydrochloride hemihydrate
por: Rousselin, Yoann, et al.
Publicado: (2012)

The Beta-1-Receptor Blocker Nebivolol Elicits Dilation of Cerebral Arteries by Reducing Smooth Muscle [Ca(2+)](i)
por: Cseplo, Peter, et al.
Publicado: (2016)

Nebivolol, a β1-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis
por: Liappas, Georgios, et al.
Publicado: (2016)

Bisoprolol in the treatment of chronic heart failure
por: de Groote, Pascal, et al.
Publicado: (2007)

Bisoprolol: Lack of efficacy: case report
Publicado: (2021)

The influence of edema on the bisoprolol blood concentration after bisoprolol dermal patch application: A case-control study
por: Takahashi, Yuji, et al.
Publicado: (2021)

The Influence of EGCG on the Pharmacokinetics and Pharmacodynamics of Bisoprolol and a New Method for Simultaneous Determination of EGCG and Bisoprolol in Rat Plasma
por: Zeng, Weiwei, et al.
Publicado: (2022)

Challenges in Interpreting Thyroid Stimulating Hormone Results in the Diagnosis of Thyroid Dysfunction
por: Razvi, Salman, et al.
Publicado: (2019)

Managing symptoms in hypothyroid patients on adequate levothyroxine: a narrative review
por: Razvi, Salman, et al.
Publicado: (2020)

Attitude of the Saudi community towards heart donation, transplantation, and artificial hearts
por: AlHabeeb, Waleed, et al.
Publicado: (2017)

Correction: Nebivolol, a β(1)-adrenergic blocker, protects from peritoneal membrane damage induced during peritoneal dialysis
por: Liappas, Georgios, et al.
Publicado: (2017)

Bisoprolol and Bisoprolol-Valsartan Compatibility Studied by Differential Scanning Calorimetry, Nuclear Magnetic Resonance and X-Ray Powder Diffractometry
por: Skotnicki, Marcin, et al.
Publicado: (2014)

Additivity of nebivolol/valsartan single‐pill combinations versus other single‐pill combinations for hypertension
por: Ishak, Jack, et al.
Publicado: (2017)

Nebivolol in the treatment of chronic heart failure
por: Veverka, Angie, et al.
Publicado: (2007)

Influence of nebivolol on anticonvulsant effect of lamotrigine
por: Goel, Radha, et al.
Publicado: (2009)

Rhabdomyolysis in a patient taking nebivolol
por: Kim, Ye Jin, et al.
Publicado: (2016)

New Data for Nebivolol after In Silico PK Study: Focus on Young Patients and Dosage Regimen
por: Marques, Lara, et al.
Publicado: (2022)

Arterial stiffness, hypertension, and rational use of nebivolol
por: Agabiti-Rosei, Enrico, et al.
Publicado: (2009)

A Review of Nebivolol Pharmacology and Clinical Evidence
por: Fongemie, Justin, et al.
Publicado: (2015)

Nebivolol Ameliorates Nitric Oxide–Deficient Hypertension
por: Fortepiani, L.A., et al.
Publicado: (2002)

Comparative effect of bisoprolol and losartan in the treatment of essential hypertension
por: Keković, Goran, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_n75qjb8vqr7a1q4dn8h6ierbjb